Cite
HARVARD Citation
Castro, G. et al. (2018). Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion‐associated graft‐versus‐host disease. Transfusion. 58 (6), pp. 1506-1515. [Online].